Global Tissue Diagnostics Industry 2016 Deep Market Research Report
- QYR617486
- 126 Pages
- June 2016
- Diagnostic and Biotech
The report provides a basic overview of the industry including definitions and classifications. The Tissue Diagnostics market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.
Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
The report focuses on global major leading industry players providing information such as company profiles, product specification, price, cost, revenue and contact information.
With 140 the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Industry Overview
1.1 Basic Information of Tissue Diagnostics
1.1.1 Definition of Tissue Diagnostics
1.1.2 Classifications of Tissue Diagnostics
1.1.2.1 Advanced Staining
1.1.2.2 Digital Pathology
1.1.2.3 Preanalytical and Routine Staining
1.1.3 Applications of Tissue Diagnostics
1.1.4 Characteristics of Tissue Diagnostics
1.2 Development Overview of Tissue Diagnostics
1.3 Enter Barriers Analysis of Tissue Diagnostics
2 Tissue Diagnostics International and China Market Analysis
2.1 Tissue Diagnostics Industry International Market Analysis
2.1.1 Tissue Diagnostics International Market Development History
2.1.2 Tissue Diagnostics Competitive Landscape Analysis
2.1.3 Tissue Diagnostics International Main Countries Development Status
2.1.4 Tissue Diagnostics International Market Development Trend
2.2 Tissue Diagnostics Industry China Market Analysis
2.2.1 Tissue Diagnostics China Market Development History
2.2.2 Tissue Diagnostics Competitive Landscape Analysis
2.2.3 Tissue Diagnostics China Main Regions Development Status
2.2.4 Tissue Diagnostics China Market Development Trend
2.3 Tissue Diagnostics International and China Market Comparison Analysis
3 Environment Analysis of Tissue Diagnostics
3.1 International Economy Analysis
3.2 China Economy Analysis
3.3 Policy Analysis of Tissue Diagnostics
3.4 News Analysis of Tissue Diagnostics
4 Analysis of Revenue by Classifications
4.1 Global Revenue of Tissue Diagnostics by Classifications 2011-2016
4.2 Global Revenue Growth Rate of Tissue Diagnostics by Classifications 2011-2016
4.3 Tissue Diagnostics Revenue by Classifications
5 Analysis of Revenue by Regions and Applications
5.1 Global Revenue of Tissue Diagnostics by Regions 2011-2016
5.2 2011-2016 USA Revenue and Revenue Growth Rate of Tissue Diagnostics
5.3 2011-2016 Europe Revenue and Revenue Growth Rate of Tissue Diagnostics
5.4 2011-2016 Japan Revenue and Revenue Growth Rate of Tissue Diagnostics
5.5 2011-2016 China Revenue and Revenue Growth Rate of Tissue Diagnostics
6 Analysis of Tissue Diagnostics Revenue Market Status 2011-2016
6.1 Revenue of Tissue Diagnostics 2011-2016
6.2 Revenue Market Share Analysis of Tissue Diagnostics 2011-2016
6.3 Revenue Overview of Tissue Diagnostics 2011-2016
6.4 Gross Margin of Tissue Diagnostics 2011-2016
7 Analysis of Tissue Diagnostics Industry Key Manufacturers
7.1 Abbott Diagnostics
7.1.1 Company Profile
7.1.2 Revenue and Gross Margin
7.1.3 Abbott Diagnostics SWOT Analysis
7.2 Agilent Technologies (a parent company of Dako)
7.2.1 Company Profile
7.2.2 Revenue and Gross Margin
7.2.3 Agilent Technologies (a parent company of Dako) SWOT Analysis
7.3 Danaher (a parent company of Leica Biosystems)
7.3.1 Company Profile
7.3.2 Revenue and Gross Margin
7.3.3 Danaher (a parent company of Leica Biosystems) SWOT Analysis
7.4 Roche Diagnostics
7.4.1 Company Profile
7.4.2 Revenue and Gross Margin
7.4.3 Roche Diagnostics SWOT Analysis
7.5 20/20 GeneSystems
7.5.1 Company Profile
7.5.2 Revenue and Gross Margin
7.5.3 20/20 GeneSystems SWOT Analysis
7.6 Abcam
7.6.1 Company Profile
7.6.2 Revenue and Gross Margin
7.6.3 Abcam SWOT Analysis
7.7 AdnaGen
7.7.1 Company Profile
7.7.2 Revenue and Gross Margin
7.7.3 AdnaGen SWOT Analysis
7.8 Advanced Cell Diagnostics
7.8.1 Company Profile
7.8.2 Revenue and Gross Margin
7.8.3 Advanced Cell Diagnostics SWOT Analysis
7.9 Affymetrix
7.9.1 Company Profile
7.9.2 Revenue and Gross Margin
7.9.3 Affymetrix SWOT Analysis
7.10 Agendia
7.10.1 Company Profile
7.10.2 Revenue and Gross Margin
7.10.3 Agendia SWOT Analysis
7.11 AutoGenomics
7.11.1 Company Profile
7.11.2 Revenue and Gross Margin
7.11.3 AutoGenomics SWOT Analysis
7.12 AVIVA BioSciences
7.12.1 Company Profile
7.12.2 Revenue and Gross Margin
7.12.3 AVIVA BioSciences SWOT Analysis
7.13 Biocare Medical
7.13.1 Company Profile
7.13.2 Revenue and Gross Margin
7.13.3 Biocare Medical SWOT Analysis
7.14 Biocartis
7.14.1 Company Profile
7.14.2 Revenue and Gross Margin
7.14.3 Biocartis SWOT Analysis
7.15 Cancer Genetics
7.15.1 Company Profile
7.15.2 Revenue and Gross Margin
7.15.3 Cancer Genetics SWOT Analysis
7.16 ELITechGroup
7.16.1 Company Profile
7.16.2 Revenue and Gross Margin
7.16.3 ELITechGroup SWOT Analysis
7.17 Enzo Biochem
7.17.1 Company Profile
7.17.2 Revenue and Gross Margin
7.17.3 Enzo Biochem SWOT Analysis
7.18 Epic Sciences
7.18.1 Company Profile
7.18.2 Revenue and Gross Margin
7.18.3 Epic Sciences SWOT Analysis
7.19 Fluidigm
7.19.1 Company Profile
7.19.2 Revenue and Gross Margin
7.19.3 Fluidigm SWOT Analysis
7.20 HORIBA Medical
7.20.1 Company Profile
7.20.2 Revenue and Gross Margin
7.20.3 HORIBA Medical SWOT Analysis
7.21 Janssen Diagnostics
7.21.1 Company Profile
7.21.2 Revenue and Gross Margin
7.21.3 Janssen Diagnostics SWOT Analysis
7.22 Olympus Diagnostics Systems Group
7.22.1 Company Profile
7.22.2 Revenue and Gross Margin
7.22.3 Olympus Diagnostics Systems Group SWOT Analysis
7.23 Omnyx (a joint venture of GE Healthcare and the University of Pittsburgh Medical Center, US)
7.23.1 Company Profile
7.23.2 Revenue and Gross Margin
7.23.3 Omnyx (a joint venture of GE Healthcare and the University of Pittsburgh Medical Center, US) SWOT Analysis
7.24 Oxford Gene Technology
7.24.1 Company Profile
7.24.2 Revenue and Gross Margin
7.24.3 Oxford Gene Technology SWOT Analysis
7.25 PANAGENE
7.25.1 Company Profile
7.25.2 Revenue and Gross Margin
7.25.3 PANAGENE SWOT Analysis
7.26 Protea Biosciences Group
7.26.1 Company Profile
7.26.2 Revenue and Gross Margin
7.26.3 Protea Biosciences Group SWOT Analysis
7.27 Sakura Finetek
7.27.1 Company Profile
7.27.2 Revenue and Gross Margin
7.27.3 Sakura Finetek SWOT Analysis
8 Sales Price and Gross Margin Analysis
8.1 Sales Price Analysis of Tissue Diagnostics
8.2 Gross Margin Analysis of Tissue Diagnostics
9 Marketing Trader or Distributor Analysis of Tissue Diagnostics
9.1 Marketing Channels Status of Tissue Diagnostics
9.2 How Countries Meet Their Needs
9.2.1 USA
9.2.2 China
9.2.3 Japan
9.2.4 Germany
10 Development Trend of Tissue Diagnostics Industry 2016-2021
10.1 Revenue Overview of Tissue Diagnostics 2016-2021
10.2 Sales Price Overview of Tissue Diagnostics 2016-2021
11 Industry Chain Suppliers of Tissue Diagnostics with Contact Information
11.1 Equipment Suppliers of Tissue Diagnostics with Contact Information
11.2 Major Suppliers of Tissue Diagnostics with Contact Information
11.3 Key Consumers of Tissue Diagnostics with Contact Information
11.4 Supply Chain Relationship Analysis of Tissue Diagnostics
12 New Project Investment Feasibility Analysis of Tissue Diagnostics
12.1 New Project SWOT Analysis of Tissue Diagnostics
12.2 New Project Investment Feasibility Analysis of Tissue Diagnostics
13 Conclusion of the Global Tissue Diagnostics Industry 2015 Market Research Report
Table Classifications of Tissue Diagnostics
Table Applications of Tissue Diagnostics
Table Policy of Tissue Diagnostics
Table Industry News List of Tissue Diagnostics
Table Global Revenue of Tissue Diagnostics by Classifications 2011-2016 (M USD)
Table Global Revenue Market Share of Tissue Diagnostics by Classifications 2011-2016
Figure Global Revenue Market Share of Tissue Diagnostics by Classifications in 2011
Figure Global Revenue Market Share of Tissue Diagnostics by Classifications in 2015
Figure Global Revenue Growth Rate of Type One 2011-2016
Figure Global Revenue Growth Rate of Type Two 2011-2016
Figure Global Revenue Growth Rate of Type Three 2011-2016
Table USA Tissue Diagnostics Revenue by Classifications
Table Europe Tissue Diagnostics Revenue by Classifications
Table Japan Tissue Diagnostics Revenue by Classifications
Table China Tissue Diagnostics Revenue by Classifications
Table Global Revenue of Tissue Diagnostics by Regions 2011-2016 (M USD)
Table Global Revenue Market Share of Tissue Diagnostics by Regions 2011-2016
Figure Global Revenue Market Share of Tissue Diagnostics by Regions in 2011
Figure Global Revenue Market Share of Tissue Diagnostics by Regions in 2015
Figure USA Tissue Diagnostics Revenue by Applications
Figure USA Tissue Diagnostics Revenue and Revenue Growth Rate
Figure Europe Tissue Diagnostics Revenue by Applications
Figure Europe Tissue Diagnostics Revenue and Revenue Growth Rate
Figure Japan Tissue Diagnostics Revenue by Applications
Figure Japan Tissue Diagnostics Revenue and Revenue Growth Rate
Figure China Tissue Diagnostics Revenue by Applications
Figure China Tissue Diagnostics Revenue and Revenue Growth Rate
Table Global and China Major Players Tissue Diagnostics Revenue of 2011-2016 (M USD)
Table Global and China Major Players Tissue Diagnostics Revenue Market Share of 2011-2016
Table China Major Players Tissue Diagnostics Revenue of 2011-2016 (M USD)
Table China Major Players Tissue Diagnostics Revenue Market Share of 2011-2016
Figure Global Revenue Market Share of Major Tissue Diagnostics Players in 2011
Figure Global Revenue Market Share of Major Tissue Diagnostics Players in 2015
Figure China Revenue Market Share Major Tissue Diagnostics Players in 2011
Figure China Revenue Market Share Major Tissue Diagnostics Players in 2015
Figure Global Revenue and Growth Rate of Tissue Diagnostics 2011-2016
Figure China Revenue and Growth Rate of Tissue Diagnostics 2011-2016
Figure 2011-2016 Global and China Tissue Diagnostics Revenue Comparison
Table Cost of Global Tissue Diagnostics Major Players 2011-2016 (M USD)
Table Gross of Global Tissue Diagnostics Major Players 2011-2016 (M USD)
Table Gross Margin of Global Tissue Diagnostics Major Players 2011-2016
Figure Gross Margin of Global Tissue Diagnostics Major Players in 2015
Table Company Profile List of Abbott Diagnostics
Table Tissue Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Abbott Diagnostics 2011-2016
Figure Tissue Diagnostics Revenue and Growth Rate of Abbott Diagnostics 2011-2016
Table SWOT Analysis of Abbott Diagnostics 2011-2016
Table Company Profile List of Agilent Technologies (a parent company of Dako)
Table Tissue Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Agilent Technologies (a parent company of Dako) 2011-2016
Figure Tissue Diagnostics Revenue and Growth Rate of Agilent Technologies (a parent company of Dako) 2011-2016
Table SWOT Analysis of Agilent Technologies (a parent company of Dako) 2011-2016
Table Company Profile List of Danaher (a parent company of Leica Biosystems)
Table Tissue Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Danaher (a parent company of Leica Biosystems) 2011-2016
Figure Tissue Diagnostics Revenue and Growth Rate of Danaher (a parent company of Leica Biosystems) 2011-2016
Table SWOT Analysis of Danaher (a parent company of Leica Biosystems) 2011-2016
Table Company Profile List of Roche Diagnostics
Table Tissue Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Roche Diagnostics 2011-2016
Figure Tissue Diagnostics Revenue and Growth Rate of Roche Diagnostics 2011-2016
Table SWOT Analysis of Roche Diagnostics 2011-2016
Table Company Profile List of 20/20 GeneSystems
Table Tissue Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of 20/20 GeneSystems 2011-2016
Figure Tissue Diagnostics Revenue and Growth Rate of 20/20 GeneSystems 2011-2016
Table SWOT Analysis of 20/20 GeneSystems 2011-2016
Table Company Profile List of Abcam
Table Tissue Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Abcam 2011-2016
Figure Tissue Diagnostics Revenue and Growth Rate of Abcam 2011-2016
Table SWOT Analysis of Abcam 2011-2016
Table Company Profile List of AdnaGen
Table Tissue Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of AdnaGen 2011-2016
Figure Tissue Diagnostics Revenue and Growth Rate of AdnaGen 2011-2016
Table SWOT Analysis of AdnaGen 2011-2016
Table Company Profile List of Advanced Cell Diagnostics
Table Tissue Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Advanced Cell Diagnostics 2011-2016
Figure Tissue Diagnostics Revenue and Growth Rate of Advanced Cell Diagnostics 2011-2016
Table SWOT Analysis of Advanced Cell Diagnostics 2011-2016
Table Company Profile List of Affymetrix
Table Tissue Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Affymetrix 2011-2016
Figure Tissue Diagnostics Revenue and Growth Rate of Affymetrix 2011-2016
Table SWOT Analysis of Affymetrix 2011-2016
Table Company Profile List of Agendia
Table Tissue Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Agendia 2011-2016
Figure Tissue Diagnostics Revenue and Growth Rate of Agendia 2011-2016
Table SWOT Analysis of Agendia 2011-2016
Table Company Profile List of AutoGenomics
Table Tissue Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of AutoGenomics 2011-2016
Figure Tissue Diagnostics Revenue and Growth Rate of AutoGenomics 2011-2016
Table SWOT Analysis of AutoGenomics 2011-2016
Table Company Profile List of AVIVA BioSciences
Table Tissue Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of AVIVA BioSciences 2011-2016
Figure Tissue Diagnostics Revenue and Growth Rate of AVIVA BioSciences 2011-2016
Table SWOT Analysis of AVIVA BioSciences 2011-2016
Table Company Profile List of Biocare Medical
Table Tissue Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Biocare Medical 2011-2016
Figure Tissue Diagnostics Revenue and Growth Rate of Biocare Medical 2011-2016
Table SWOT Analysis of Biocare Medical 2011-2016
Table Company Profile List of Biocartis
Table Tissue Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Biocartis 2011-2016
Figure Tissue Diagnostics Revenue and Growth Rate of Biocartis 2011-2016
Table SWOT Analysis of Biocartis 2011-2016
Table Company Profile List of Cancer Genetics
Table Tissue Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Cancer Genetics 2011-2016
Figure Tissue Diagnostics Revenue and Growth Rate of Cancer Genetics 2011-2016
Table SWOT Analysis of Cancer Genetics 2011-2016
Table Company Profile List of ELITechGroup
Table Tissue Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of ELITechGroup 2011-2016
Figure Tissue Diagnostics Revenue and Growth Rate of ELITechGroup 2011-2016
Table SWOT Analysis of ELITechGroup 2011-2016
Table Company Profile List of Enzo Biochem
Table Tissue Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Enzo Biochem 2011-2016
Figure Tissue Diagnostics Revenue and Growth Rate of Enzo Biochem 2011-2016
Table SWOT Analysis of Enzo Biochem 2011-2016
Table Company Profile List of Epic Sciences
Table Tissue Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Epic Sciences 2011-2016
Figure Tissue Diagnostics Revenue and Growth Rate of Epic Sciences 2011-2016
Table SWOT Analysis of Epic Sciences 2011-2016
Table Company Profile List of Fluidigm
Table Tissue Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Fluidigm 2011-2016
Figure Tissue Diagnostics Revenue and Growth Rate of Fluidigm 2011-2016
Table SWOT Analysis of Fluidigm 2011-2016
Table Company Profile List of HORIBA Medical
Table Tissue Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of HORIBA Medical 2011-2016
Figure Tissue Diagnostics Revenue and Growth Rate of HORIBA Medical 2011-2016
Table SWOT Analysis of HORIBA Medical 2011-2016
Table Company Profile List of Janssen Diagnostics
Table Tissue Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Janssen Diagnostics 2011-2016
Figure Tissue Diagnostics Revenue and Growth Rate of Janssen Diagnostics 2011-2016
Table SWOT Analysis of Janssen Diagnostics 2011-2016
Table Company Profile List of Olympus Diagnostics Systems Group
Table Tissue Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Olympus Diagnostics Systems Group 2011-2016
Figure Tissue Diagnostics Revenue and Growth Rate of Olympus Diagnostics Systems Group 2011-2016
Table SWOT Analysis of Olympus Diagnostics Systems Group 2011-2016
Table Company Profile List of Omnyx (a joint venture of GE Healthcare and the University of Pittsburgh Medical Center, US)
Table Tissue Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Omnyx (a joint venture of GE Healthcare and the University of Pittsburgh Medical Center, US) 2011-2016
Figure Tissue Diagnostics Revenue and Growth Rate of Omnyx (a joint venture of GE Healthcare and the University of Pittsburgh Medical Center, US) 2011-2016
Table SWOT Analysis of Omnyx (a joint venture of GE Healthcare and the University of Pittsburgh Medical Center, US) 2011-2016
Table Company Profile List of Oxford Gene Technology
Table Tissue Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Oxford Gene Technology 2011-2016
Figure Tissue Diagnostics Revenue and Growth Rate of Oxford Gene Technology 2011-2016
Table SWOT Analysis of Oxford Gene Technology 2011-2016
Table Company Profile List of PANAGENE
Table Tissue Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of PANAGENE 2011-2016
Figure Tissue Diagnostics Revenue and Growth Rate of PANAGENE 2011-2016
Table SWOT Analysis of PANAGENE 2011-2016
Table Company Profile List of Protea Biosciences Group
Table Tissue Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Protea Biosciences Group 2011-2016
Figure Tissue Diagnostics Revenue and Growth Rate of Protea Biosciences Group 2011-2016
Table SWOT Analysis of Protea Biosciences Group 2011-2016
Table Company Profile List of Sakura Finetek
Table Tissue Diagnostics Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Sakura Finetek 2011-2016
Figure Tissue Diagnostics Revenue and Growth Rate of Sakura Finetek 2011-2016
Table SWOT Analysis of Sakura Finetek 2011-2016
Figure Tissue Diagnostics Manufactor Profit Model
Figure Marketing Channels Status of Tissue Diagnostics
Figure Global Revenue and Growth Rate of Tissue Diagnostics 2016-2021
Figure China Revenue and Growth Rate of Tissue Diagnostics 2016-2021
Figure Global and China Tissue Diagnostics Revenue Comparison 2016-2021
Table Equipment Suppliers of Tissue Diagnostics with Contact Information
Table Major Suppliers of Tissue Diagnostics with Contact Information
Table Key Consumers of Tissue Diagnostics with Contact Information
Figure Supply Chain Relationship Analysis of Tissue Diagnostics
Table New Project SWOT Analysis of Tissue Diagnostics
Similar Reports
Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950.
Summary
This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market duri...
- Publish Date: February 7, 2017
- $750
Complete report $9,600. DataPack (test volumes, sales forecasts, supplier shares) $6,200.
Summary
This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the...
- Publish Date: February 7, 2017
- $750
This new report from VPGMarketResearch.com provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
Con...
- Publish Date: February 7, 2017
- $750
